Palisade Bio Director Buys 5,000 Shares Amid Quiet Insider Buying Surge.
Insider buying at Palisade Bio shows executive confidence: Donald Allen’s 5,000‑share purchase amid modest volatility signals optimism for the GI therapy launch.
3 minutes to read